Loading Dose of tPA for Acute Ischemic Stroke

Dosing Protocol

• The American College of Emergency Physicians recommends a loading dose of tissue plasminogen activator (tPA) for acute ischemic stroke of 0.9 mg/kg (maximum 90 mg total), with 10% of the total calculated dose administered as an intravenous bolus over 1 minute, followed by the remaining 90% infused over 60 minutes 1, 2
• The standard dosing regimen is: Total dose: 0.9 mg/kg (not to exceed 90 mg maximum) 1, 2
• The initial bolus is 10% of the total dose administered intravenously over 1 minute 1
• The remaining 90% is infused over 60 minutes 1

Time Window Considerations

• The American College of Chest Physicians recommends tPA within 3 hours of symptom onset with a strong recommendation (Grade 1A) 2, 3
• The American College of Chest Physicians recommends tPA between 3-4.5 hours of symptom onset with a conditional recommendation (Grade 2C) 2, 3
• The American College of Chest Physicians contraindicates tPA beyond 4.5 hours (Grade 1B) 2, 3

Special Populations

• Patients on direct oral anticoagulants (DOACs) like apixaban should NOT receive tPA as routine practice due to substantially elevated bleeding risk 4
• For patients on antiplatelet therapy prior to stroke, the same 0.9 mg/kg dose is used, though there is a 3% absolute increased risk of symptomatic ICH compared to those not on antiplatelet therapy 5

General Considerations

• The baseline symptomatic intracranial hemorrhage rate with proper dosing is 4-6%, which increases substantially with dosing errors or in anticoagulated patients 4
• The NINDS trial showed that symptomatic ICH occurred in 6.4% of tPA-treated patients versus 0.6% of placebo patients 1
• The absolute benefit of tPA is greatest when treatment is initiated earliest, with earlier treatment resulting in greater proportional benefit 6

Thrombolysis in Minor Stroke

Evidence Supporting Treatment

• The Canadian Stroke Best Practice Recommendations state that eligible patients should receive intravenous tPA within 4.5 hours of symptom onset, without excluding minor strokes from this recommendation, as per the International Journal of Stroke 7
• Administer tPA at the standard dose of 0.9 mg/kg (maximum 90 mg total), with 10% given as an IV bolus over 1 minute and the remaining 90% infused over 60 minutes, as recommended by the International Journal of Stroke 7

Treatment Protocol

• For patients with minor stroke, treatment is strongly recommended within 0-3 hours (Grade 1A) and conditionally recommended within 3-4.5 hours (Grade 2C), as per Chest 8
• After tPA administration (or if tPA is contraindicated), initiate aspirin 160-325 mg within 24-48 hours for patients not receiving anticoagulation, as recommended by Chest 8

Post-Treatment Management

• For minor stroke or high-risk TIA, dual antiplatelet therapy with aspirin plus clopidogrel for 21 days is conditionally recommended when initiated within 12-24 hours, although the specific guideline society is not mentioned in the provided reference 8
• The American Heart Association guidelines note that patients with mild to moderate strokes (NIHSS <20) and those <75 years of age had the greatest potential for excellent outcomes with treatment, but this does not exclude older patients or those with more severe strokes from consideration, as per Stroke 9

When to Consult

• When uncertainty exists about whether to treat a minor stroke patient with tPA, urgently consult with a stroke specialist within the institution or through telestroke services, as recommended by the International Journal of Stroke and Stroke [7] [9]

rtPA Administration Protocol for Acute Ischemic Stroke

Pre-Administration Requirements

• The American Heart Association recommends blood pressure be reduced to <185/110 mm Hg before initiating rtPA, or the drug should not be given, with labetalol or nicardipine used for blood pressure control 10, 11
• If blood pressure cannot be controlled below these thresholds, rtPA is contraindicated, as stated by the American College of Cardiology 11, 12

Administration Protocol

• The American Heart Association recommends administering rtPA at 0.9 mg/kg (maximum 90 mg total) with 10% given as an IV bolus over 1 minute, followed by the remaining 90% infused over 60 minutes 10
• Calculate total dose: patient weight in kg (maximum 100 kg) × 0.9 mg/kg, with a maximum total dose of 90 mg regardless of actual weight, as recommended by the American College of Cardiology 10, 13

Post-Administration Monitoring

• The American Heart Association recommends monitoring blood pressure every 15 minutes during infusion and for 2 hours after, then every 30 minutes for 6 hours, then hourly for 16 hours, with blood pressure maintained <180/105 mm Hg during and after treatment 10, 11
• Do NOT give anticoagulants or antiplatelet agents for 24 hours after rtPA administration, as stated by the American College of Cardiology 14

Time Window Considerations

• Earlier treatment within 90 minutes provides greatest benefit (odds ratio 2.11 vs 1.69 for 90-180 minutes), as reported by the American Heart Association 14

Critical Contraindications

• If systolic remains >185 mm Hg or diastolic >110 mm Hg despite treatment, rtPA is absolutely contraindicated, as stated by the American College of Cardiology 10, 11, 12

Expected Complications

• Symptomatic intracranial hemorrhage occurs in 6.4% of rtPA-treated patients vs 0.6% of placebo patients, as reported by the American Heart Association 14

Alternative Approach: Intra-arterial Thrombolysis

• Intra-arterial rtPA extends treatment window to 6 hours after symptom onset in selected cases, as recommended by the American College of Cardiology 10, 13
• Consider for patients beyond IV window or with contraindications to IV therapy, as stated by the American Heart Association 15

Acute Ischemic Stroke Treatment with tPA

Clinical Efficacy and Time-Dependent Benefits

• The American Heart Association recommends tPA treatment within 3 hours of acute ischemic stroke onset, resulting in an absolute difference of 13% for excellent functional outcomes, with a number needed to treat of 8 16
• The benefit of tPA is highly time-dependent, with earlier treatment producing substantially better outcomes, and the odds ratio for good outcome is 2.55 when given within 0-90 minutes, 1.64 when given within 91-180 minutes, and 1.32 when given within 181-270 minutes 17

Time Window Stratification

• The American Stroke Association suggests that tPA treatment within 0-90 minutes has the greatest benefit, with an odds ratio of 2.55 for good outcome 17